These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1133220)

  • 1. Intense surveillance of adverse drug reactions. An analysis of 338 patients.
    Vakil BJ; Kulkarni RD; Chabria NL; Chadha DR; Deshpande VA
    J Clin Pharmacol; 1975; 15(5-6):435-41. PubMed ID: 1133220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive drug surveillance--a pilot study.
    Gerke DC; Easterbrook EG; Frewin DB; Lee TI
    Aust N Z J Med; 1975 Aug; 5(4):336-40. PubMed ID: 1058672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
    Fiszenson-Albala F; Auzerie V; Mahe E; Farinotti R; Durand-Stocco C; Crickx B; Descamps V
    Br J Dermatol; 2003 Nov; 149(5):1018-22. PubMed ID: 14632808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of 10% in the Rate of Adverse Drug Reactions for Each Drug Administered in Hospitalized Patients.
    Ribeiro MR; Motta AA; Marcondes-Fonseca LA; Kalil-Filho J; Giavina-Bianchi P
    Clinics (Sao Paulo); 2018; 73():e185. PubMed ID: 29451619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.
    Dormann H; Muth-Selbach U; Krebs S; Criegee-Rieck M; Tegeder I; Schneider HT; Hahn EG; Levy M; Brune K; Geisslinger G
    Drug Saf; 2000 Feb; 22(2):161-8. PubMed ID: 10672897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the adverse drug reaction surveillance system Kadoma City, Zimbabwe 2015.
    Muringazuva C; Chirundu D; Mungati M; Shambira G; Gombe N; Bangure D; Juru T; Tshimanga M
    Pan Afr Med J; 2017; 27():55. PubMed ID: 28819477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive hospital monitoring of adverse reactions to drugs.
    Hurwitz N; Wade OL
    Br Med J; 1969 Mar; 1(5643):531-6. PubMed ID: 5764699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-related variations in the frequency and characteristics of adverse drug reactions.
    Domecq C; Naranjo CA; Ruiz I; Busto U
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):362-6. PubMed ID: 7409941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug utilization and reported adverse reactions in hospitalized children.
    Mitchell AA; Goldman P; Shapiro S; Slone D
    Am J Epidemiol; 1979 Aug; 110(2):196-204. PubMed ID: 463874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?
    Carbonin P; Pahor M; Bernabei R; Sgadari A
    J Am Geriatr Soc; 1991 Nov; 39(11):1093-9. PubMed ID: 1753048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between number of drugs and duration of hospital stay in older patients with neuromuscular diseases.
    Nishida S; Hayashi Y; Suzuki A; Kobayashi R; Inuzuka T; Itoh Y
    Geriatr Gerontol Int; 2018 Jul; 18(7):1018-1024. PubMed ID: 29512265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay.
    Hanlon JT; Pieper CF; Hajjar ER; Sloane RJ; Lindblad CI; Ruby CM; Schmader KE
    J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):511-5. PubMed ID: 16720750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations.
    Wang C; Shi QP; Ding F; Jiang XD; Tang W; Yu ML; Cheng JQ
    Biomed Pharmacother; 2019 Jan; 109():1523-1531. PubMed ID: 30551404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions: an investigation on an acute geriatric ward.
    Leach S; Roy SS
    Age Ageing; 1986 Jul; 15(4):241-6. PubMed ID: 3751750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic impact of adverse drug reactions in hospitalized patients.
    Suh DC; Woodall BS; Shin SK; Hermes-De Santis ER
    Ann Pharmacother; 2000 Dec; 34(12):1373-9. PubMed ID: 11144691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.